Category WTO/TRIPS

Group Calls On WTO Members To Make Trade Rules Development Compatible

A group of civil society organisations is calling for endorsements of a letter to the World Trade Organization prior to the upcoming Ministerial meeting in December aimed at preventing alleged efforts by rich countries to tighten international trade rules and introduce corporate “wish-list” issues from free trade agreements into the WTO.

WTO Committee Agrees To Keep IP From Non-Violation Complaints Until 2017

Today, the World Trade Organisation intellectual property committee agreed on a recommendation to extend until 2017 a moratorium shielding intellectual property from a mechanism through which one WTO member can go after another member even in the absence of WTO rules infringement.

WTO Discussions On Non-Violation Complaints Might Be Near Consensus, Sources Say

Last month, the World Trade Organization committee on intellectual property was suspended over two contentious items. One item left open is the proposed extension of a moratorium which leaves intellectual property outside of a mechanism through which one WTO member can go after another despite no violation of a WTO agreement. According to sources, a solution might be within reach.

Governments, Industry Offer Mixed Hope For Multilateral IP Policymaking

WASHINGTON, DC -- The sun may be setting on multilateral policymaking in intellectual property in the eyes of industry, but leading United States and European Union representatives insist on its continued vital role in trade and economy. But a “new narrative” is needed as they emphasise bilateral and plurilateral agreements.

EU Trademark Reform Advances; Dutch Warn Of Holdup Of Goods In Transit

The European Union Council of ministers today adopted its position on the reform of the European trademark system. The Netherlands delegation abstained from voting out of concern that the proposed reform introduces the possibility to stop goods in transit for possible intellectual property infringement.

LDC Pharma IP Waiver Until 2033 Approved By WTO TRIPS Council

After two weeks of high level negotiations between the United States and the Group of Least-Developed Countries, the World Trade Organization committee on intellectual property rights today agreed to extend a waiver allowing LDCs to avoid applying and enforcing IP rights on pharmaceutical products until 2033.

17 Year Exemption From Pharmaceutical Patents Agreed At WTO – TWN

From Third World Network: London, 3 Nov (Sangeeta Shashikant) ­ The United States and the Least Developed Countries (LDCs) at the World Trade Organization have reached agreement ad referendum on a pharmaceutical patent exemption for a duration of 17 years, according to trade diplomats.